Cargando…
New genomic techniques and their European Union reform. Potential policy changes and their implications
The article discusses amendment options (no significant change, lowering of administrative burdens or exemption of certain products from the legislation) for the European Union (EU) authorization procedures of New Genomic Techniques’ (NGT) products and their consequences for the sector and research...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562193/ https://www.ncbi.nlm.nih.gov/pubmed/36246372 http://dx.doi.org/10.3389/fbioe.2022.1019081 |
_version_ | 1784808115360759808 |
---|---|
author | Zimny, Tomasz |
author_facet | Zimny, Tomasz |
author_sort | Zimny, Tomasz |
collection | PubMed |
description | The article discusses amendment options (no significant change, lowering of administrative burdens or exemption of certain products from the legislation) for the European Union (EU) authorization procedures of New Genomic Techniques’ (NGT) products and their consequences for the sector and research institutions, particularly in the context of internal functioning, placing products on the market and international trade. A reform of the EU regulatory system requires a change in the procedures for the authorization of NGT products, otherwise EU researchers and investors may still be at a competitive disadvantage (as compared to Argentina, Brazil, Canada, United States or the United Kingdom) due to the inefficiency of the current system and the committee procedure for authorization. New legislation, currently being adopted in the United Kingdom is also presented for comparison. |
format | Online Article Text |
id | pubmed-9562193 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95621932022-10-15 New genomic techniques and their European Union reform. Potential policy changes and their implications Zimny, Tomasz Front Bioeng Biotechnol Bioengineering and Biotechnology The article discusses amendment options (no significant change, lowering of administrative burdens or exemption of certain products from the legislation) for the European Union (EU) authorization procedures of New Genomic Techniques’ (NGT) products and their consequences for the sector and research institutions, particularly in the context of internal functioning, placing products on the market and international trade. A reform of the EU regulatory system requires a change in the procedures for the authorization of NGT products, otherwise EU researchers and investors may still be at a competitive disadvantage (as compared to Argentina, Brazil, Canada, United States or the United Kingdom) due to the inefficiency of the current system and the committee procedure for authorization. New legislation, currently being adopted in the United Kingdom is also presented for comparison. Frontiers Media S.A. 2022-09-30 /pmc/articles/PMC9562193/ /pubmed/36246372 http://dx.doi.org/10.3389/fbioe.2022.1019081 Text en Copyright © 2022 Zimny. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Zimny, Tomasz New genomic techniques and their European Union reform. Potential policy changes and their implications |
title | New genomic techniques and their European Union reform. Potential policy changes and their implications |
title_full | New genomic techniques and their European Union reform. Potential policy changes and their implications |
title_fullStr | New genomic techniques and their European Union reform. Potential policy changes and their implications |
title_full_unstemmed | New genomic techniques and their European Union reform. Potential policy changes and their implications |
title_short | New genomic techniques and their European Union reform. Potential policy changes and their implications |
title_sort | new genomic techniques and their european union reform. potential policy changes and their implications |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562193/ https://www.ncbi.nlm.nih.gov/pubmed/36246372 http://dx.doi.org/10.3389/fbioe.2022.1019081 |
work_keys_str_mv | AT zimnytomasz newgenomictechniquesandtheireuropeanunionreformpotentialpolicychangesandtheirimplications |